Pharmaceutical and agrochemical company
Bayer wants to save two billion from 2026
The company logo lights up on the factory premises in Leverkusen. photo
© Thomas Banneyer/dpa
Bayer wants to save no less than two billion euros in organizational costs annually from 2026. However, there are currently no plans to split up.
The pharmaceutical and agricultural chemicals group Bayer is trying to master its difficult situation without selling off its divisions despite high debts. The answer to the question about the future structure and a possible split is “not now,” the DAX company announced on Tuesday as part of the presentation of annual figures and a capital market day. Nevertheless, “we will remain open to everything,” said Bayer boss Bill Anderson, according to the statement. Given the very limited scope for action, business development should first be improved and more strategic flexibility created. As part of the new organizational model that has already been presented, two billion euros in organizational costs are to be saved annually from 2026.
Already had in January Bayer has announced that there will likely be a significant reduction in personnel in Germany as part of the planned streamlining of administration and the desired acceleration of decision-making processes.
As Bayer further announced on Tuesday with a view to the legal disputes in the USA, “new approaches inside and outside the courtrooms” will be pursued in order to reduce legal risks and the associated uncertainties. Investors have long criticized the fact that it has not yet been possible to draw a line under the glyphosate problem.